SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-24-030891 from CervoMed Inc. (CRVO)

CervoMed Inc.
Date: Oct. 8, 2024 · CIK: 0001053691 · Accession: 0001437749-24-030891

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282494

Date
October 8, 2024
Author
William Elder
Form
CORRESP
Company
CervoMed Inc.

Letter

crvo20241008_corresp.htm

CERVOMED INC.

20 Park Plaza

Suite 424

Boston, MA 02116

October 8, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Chris Edwards

Re:

CervoMed Inc.

Registration Statement on Form S-3 (File No. 333-282494)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, CervoMed Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 5:00 p.m., Eastern Time, on October 10, 2024, or as soon as practicable thereafter.

The Registrant requests that it be notified of such effectiveness by a telephone call to Jason S. McCaffrey, Esq., of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4416 or by an email to JSMcCaffrey@mintz.com.

Thank you for your assistance. If you should have any questions, please contact Mr. McCaffrey at (617) 348-4416.

Very truly yours,
CERVOMED INC.

Show Raw Text
CORRESP
1
filename1.htm

	crvo20241008_corresp.htm

CERVOMED INC.

20 Park Plaza

Suite 424

Boston, MA 02116

October 8, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Chris Edwards

			Re:

			CervoMed Inc.

			Registration Statement on Form S-3 (File No. 333-282494)

			Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, CervoMed Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 5:00 p.m., Eastern Time, on October 10, 2024, or as soon as practicable thereafter.

The Registrant requests that it be notified of such effectiveness by a telephone call to Jason S. McCaffrey, Esq., of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4416 or by an email to JSMcCaffrey@mintz.com.

Thank you for your assistance. If you should have any questions, please contact Mr. McCaffrey at (617) 348-4416.

			Very truly yours,

			CERVOMED INC.

			By: /s/ William Elder

			Name: William Elder

			Title:   Chief Financial Officer, General Counsel and Corporate Secretary